FARMINGDALE, N.Y.--(BUSINESS WIRE)--Misonix, Inc. (NASDAQ:MSON), a developer of ultrasonic medical device technology for the treatment of cancer and other chronic health conditions, today announced that it has entered into a credit security agreement with Wells Fargo Bank, National Association, (NYSE:WFC), acting through its Wells Fargo Business Credit operating division, for a revolving note facility up to $8 million. Wells Fargo Bank has the highest possible credit rating of “Aaa” from Moody’s Investors Service and the highest credit rating given to a U.S. bank of “AA+” from Standard & Poor’s Ratings Services. The revolving note with Wells Fargo Bank will replace the Company’s existing $2 million revolving credit facility with Bank of America.
